For example, HSF1-MTA1 complexes were involved in repressing estrogen receptor (ER)-regulated genes, a stage in the switch from more benign estrogen-dependent luminal breast cancers to the more metastatic Her2 phenotype [125,126]. This evidence concerns the gene MTA1 and breast carcinoma.